No / Lipidomics aim to generate qualitative and quantitative information on different classes of lipids and their species, and when applied in conjunction with proteomic and genomic assays, facilitate the comprehensive study of lipid metabolism in cellular, organ or body systems. Advances in mass spectrometry have underpinned the expansion of lipidomic methodologies. Prostanoids are potent autacoids present in a plethora of cellular systems, known best for their intimate role in inflammation. Electrospray ionisation (ESI) allows the efficient ionisation of prostanoids in aqueous systems. ESI can be readily coupled to liquid chromatography (LC) followed by tandem mass spectrometry (MS/MS)-based detection, thus allowing the development of a potent and selective LC/ESI-MS/MS quantitative assays. The protocol we describe in this chapter outlines the steps we follow to a) extract prostanoids from solid or liquid samples, b) semi-purify the metabolites using solid phase extraction c) set-up the HPLC separation using reverse phase chromatography and d) set up the MS/MS assay using a triple quadrupole mass spectrometer. The experimental details and notes presented here are based on the detailed protocols followed in our group

In dieser Arbeit konnte ein humaner IgG1-Antikörper mittels verschiedener massenspektrometrischer Methoden erfolgreich untersucht und charakterisiert werden. Neben der Bestimmung der molekularen Massen des betrachteten Anti-Interleukin-8-Antikörpers und dessen Fragmenten konnte auch die Bildung von Oligomeren untersucht werden. Es wurden verschiedene Oligomere, bis hin zum Pentamer, massenspektrometrisch gemessen und es konnten auch Erkenntnisse gewonnen werden, dass Konzentrationseffekte maßgeblich zur Oligomerbildung bei diesem Antikörper beitragen. Die Antikörperglykosylierung, eine sehr prominente und hoch diverse Modifikation, wurde bei diesem Antikörper ebenfalls gefunden und neben dem intakten Antikörper auch in dessen Fragmenten und im Dimer gemessen. Neben dieser natürlichen Modifikation wurden auch Derivatisierungen des Antikörpers analysiert, dabei wurden unterschiedliche Metallmarkierungen analysiert. Es konnten verschiedene Markierungsgrade bestimmt werden, auch wenn diese nebeneinander als Mischung vorlagen. Der Nachweis, dass der Antikörper auch weiterhin intakt und bindungsfähig ist, konnte erbracht werden. Die Bildung von Komplexen des Antikörpers mit verschiedenen Proteinen konnte ebenfalls mittels Massenspektrometrie gezeigt werden. Weiterhin konnte gezeigt werden, dass es möglich war, eine Quantifizierungsstrategie für Antikörper zu entwickeln. Mit dieser können absolute Quantifizierungen durchgeführt werden, während diese gleichzeitig unabhängig von Art und Struktur des einzusetzenden Standards sind. Damit ist es möglich, die Probleme des Bradford-Assays zu umgehen. Des Weiteren sind nur minimale Kenntnisse über den zu analysierenden Antikörper notwendig, sodass dieses Verfahren auch hervorragend auf bisher nicht charakterisierte Antikörper angewendet werden kann. / The aim of this work is the characterization of an antibody. The used human IgG1-antibody was successfully investigated with various mass spectrometric methods. In addition to the determination of the molecular masses of the analyzed Anti-Interleukin-8 antibody itself and its fragments the formation of oligomers was examined. Different oligomers up to pentamers could be mass spectromatrically measured. Resulting from this, it was possible to find that concentration effects are the main factors for the oligomer formation of this particular antibody. The glycosylation of antibodies, a prominent and high diverse modification, was also found in this antibody and was measured in the intact molecule, in its fragments and also the dimer. Next to this native modification, also a derivatization of the antibody was investigated. Different metal containing modifications were analyzed. Thereby it was possible to determine various tagging degrees, even in a mixture of these metal containing modifications. The important question, whether the tagged antibody is still active and capable for binding, can be answered positively. Furthermore the formation of antibody-protein complexes could be shown via mass spectrometry. It was also successful to develop a quantification strategy for this antibody. With this an absolute quantification was possible, which was independent from the type and the structure of the used standard. With this method it is possible to overcome the problems of the Bradford assay. In addition to this only very little information about the antibody is needed for the quantification, which allows to use this method for non characterized antibodies.

Esta tese foi dividida em três capítulos. O capítulo I descreve o desenvolvimento do método Column switching UHPLC-MS/MS para a determinação simultaneamente de fármacos psicotrópicos em amostras de plasma de pacientes esquizofrênicos. A politerapia é uma prática comum no tratamento da esquizofrenia. Portanto, a monitorização terapêutica destes fármacos tem sido realizada para o ajuste das doses e individualização da terapia farmacológica. O método Column switching UHPLC-MS/MS apresentou linearidade na faixa de concentração de 0,025 a 1,25 ng mL-1 com R2 acima de 0,9950 e a falta de teste de ajuste (p > 0,05); precisão com coeficientes de variação inferiores a 12% e exatidão com erro padrão relativo inferior a 14%. Este método foi aplicado com sucesso para determinação de fármacos em amostras de plasma de pacientes esquizofrênicos para fins de monitorização terapêutica. No capítulo II, o desempenho cromatográfico de colunas C18 superficialmente e totalmente porosas com diferentes tamanhos de partícula foi avaliado para a análise de fármacos psicotrópicos por LC-MS/MS e LC-DAD. Com o sistema LC-MS/MS foram avaliados os seguintes parâmetros cromatográficos: altura do prato reduzido vs velocidade linear reduzida, impedância vs velocidade linear reduzida, tempo da corrida cromatográfica vs vazão, pressão vs vazão, resolução, capacidade de pico, assimetria e fator de retenção. Já com o sistema LC-DAD foram avaliados a hidrofobicidade, atividade silanol e impurezas metálicas também foram avaliadas. As colunas com superfície carregada apresentaram maior eficiência cromatográfica para os fármacos em sua forma ionizada. Já as colunas com partículas menores que 2 µm (Cortecs 1,6 µm, Acquity 1,7 µm, e Kinetex 1,7 µm) apresentaram maior eficiência cromatográfica para os fármacos na forma parcialmente ionizada. Os modelos matemáticos gerados foram capazes de prever a pressão e o tempo da corrida cromatográfica em diferentes vazões para todas as colunas. Considerando a eficiência, impedância, resolução, capacidade de pico, fator de retenção e hidrofobicidade, as colunas Cortecs 1,6 µm e Acquity 1,7 µm apresentaram melhor desempenho durante a análise dos fármacos em amostra de plasma. O capítulo III descreve o desenvolvimento e validação dos métodos SPME-UHPLC-MS/MS e Bio-SPME-Nano-ESI-MS/MS para a determinação dos endocanabinóides (AEA e 2-AG) em amostras biológicas. Para a otimização do processo SPME foram avaliadas as fases SPME (C18, C30 e HLB) e os solventes para dessorção (metanol, acetonitrila e isopropanol). Os aditivos modificadores de matriz, como cloridrato de guanidina, ácido trifluoroacético e acetonitrila foram avaliados por planejamento experimental. Os métodos SPME-UHPLC-MS/MS e Bio-SPME-Nano-ESI-MS/MS, com a fase HLB biocompatível, apresentaram para ambos endocanabinóides valores de LOQs de 1 ng mL-1 e 50 ng mL-1, respectivamente. O método Bio-SPME-Nano-ESI-MS/MS permitiu o direto acoplamento da fibra SPME ao espectrômetro de massas via dessorção/ionização nanoeletrospray que resultou em rápida determinação quantitativa dos endocanabinóides em amostras biológicas. / This thesis is divided into three chapters. Chapter I describes the development of a column switching UHPLCMS/MS method to determine psychotropic drugs in schizophrenic patients plasma samples simultaneously. Polytherapy is a common practice in schizophrenia treatment. Therefore, therapeutic drug monitoring has been applied to adjust doses and to customize pharmacological therapy. The column switching UHPLCMS/MS method developed here is linear at concentrations ranging from 0.025 to 1.25 ng mL-1 with R2 above 0.9950 and presents lack of fit test (p > 0.05), precision with coefficients of variation lower than 12%, and accuracy with relative standard error lower than 14%. This method was successfully applied to determine drugs in schizophrenic patients plasma samples for therapeutic drug monitoring. In chapter II, the chromatographic performance of C18 superficially porous columns and of C18 fully porous columns with different particle sizes were evaluated for analysis of psychotropic drugs by LC-MS/MS and LC-DAD. Within the LC-MS/MS system, the following chromatographic parameters were assessed: reduced plate height vs reduced linear velocity, impedance vs reduced linear velocity, chromatographic run time vs flow rate, backpressure vs flow rate, resolution, peak capacity, asymmetry, and retention factor. Within the LC-DAD system, hydrophobicity, silanol activity, and metal impurities were also examined. Columns with charged surface displayed improved chromatographic efficiency for drugs in the ionized form. Columns with particles smaller than 2 µm (Cortecs 1.6 µm, Acquity 1.7 µm, and Kinetex 1.7 µm) presented higher chromatographic efficiency for the drugs, which were in their partially ionized form. The generated mathematical models were able to predict the backpressure and the chromatographic run time at different flow rates for all the columns. Considering efficiency, impedance, resolution, peak capacity, retention factor, and hydrophobicity, columns Cortecs 1.6 µm and Acquity 1.7 µm provided the best performance during analysis of drugs in plasma samples. Chapter III describes the development and validation of the SPME-UHPLC-MS/MS and the Bio-SPME-Nano-ESI-MS/MS methods for determination of endocannabinoids (AEA and 2-AG) in biological samples. To optimize the SPME process, SPME coatings (C18, C30, and HLB) and solvents for desorption (methanol, acetonitrile, and isopropanol) were evaluated. Matrix modifier additives, such as guanidine hydrochloride, trifluoroacetic acid, and acetonitrile, were assessed by experimental design. The SPME-UHPC-MS/MS and the Bio-SPME-Nano-ESI-MS/MS methods with HLB biocompatible coating provided LOQ values of 1 ng mL-1 and 50 ng mL-1, respectively, for both endocannabinoids. The Bio-SPME-Nano-ESI-MS/MS method allowed direct coupling of SPME fibers to the mass spectrometer by desorption/ionization nanoelectrospray, which resulted in rapid quantitative determinations of endocannabinoids in biological samples.

No description available.

Esta tese foi dividida em três capítulos. O capítulo I descreve o desenvolvimento do método Column switching UHPLC-MS/MS para a determinação simultaneamente de fármacos psicotrópicos em amostras de plasma de pacientes esquizofrênicos. A politerapia é uma prática comum no tratamento da esquizofrenia. Portanto, a monitorização terapêutica destes fármacos tem sido realizada para o ajuste das doses e individualização da terapia farmacológica. O método Column switching UHPLC-MS/MS apresentou linearidade na faixa de concentração de 0,025 a 1,25 ng mL-1 com R2 acima de 0,9950 e a falta de teste de ajuste (p > 0,05); precisão com coeficientes de variação inferiores a 12% e exatidão com erro padrão relativo inferior a 14%. Este método foi aplicado com sucesso para determinação de fármacos em amostras de plasma de pacientes esquizofrênicos para fins de monitorização terapêutica. No capítulo II, o desempenho cromatográfico de colunas C18 superficialmente e totalmente porosas com diferentes tamanhos de partícula foi avaliado para a análise de fármacos psicotrópicos por LC-MS/MS e LC-DAD. Com o sistema LC-MS/MS foram avaliados os seguintes parâmetros cromatográficos: altura do prato reduzido vs velocidade linear reduzida, impedância vs velocidade linear reduzida, tempo da corrida cromatográfica vs vazão, pressão vs vazão, resolução, capacidade de pico, assimetria e fator de retenção. Já com o sistema LC-DAD foram avaliados a hidrofobicidade, atividade silanol e impurezas metálicas também foram avaliadas. As colunas com superfície carregada apresentaram maior eficiência cromatográfica para os fármacos em sua forma ionizada. Já as colunas com partículas menores que 2 µm (Cortecs 1,6 µm, Acquity 1,7 µm, e Kinetex 1,7 µm) apresentaram maior eficiência cromatográfica para os fármacos na forma parcialmente ionizada. Os modelos matemáticos gerados foram capazes de prever a pressão e o tempo da corrida cromatográfica em diferentes vazões para todas as colunas. Considerando a eficiência, impedância, resolução, capacidade de pico, fator de retenção e hidrofobicidade, as colunas Cortecs 1,6 µm e Acquity 1,7 µm apresentaram melhor desempenho durante a análise dos fármacos em amostra de plasma. O capítulo III descreve o desenvolvimento e validação dos métodos SPME-UHPLC-MS/MS e Bio-SPME-Nano-ESI-MS/MS para a determinação dos endocanabinóides (AEA e 2-AG) em amostras biológicas. Para a otimização do processo SPME foram avaliadas as fases SPME (C18, C30 e HLB) e os solventes para dessorção (metanol, acetonitrila e isopropanol). Os aditivos modificadores de matriz, como cloridrato de guanidina, ácido trifluoroacético e acetonitrila foram avaliados por planejamento experimental. Os métodos SPME-UHPLC-MS/MS e Bio-SPME-Nano-ESI-MS/MS, com a fase HLB biocompatível, apresentaram para ambos endocanabinóides valores de LOQs de 1 ng mL-1 e 50 ng mL-1, respectivamente. O método Bio-SPME-Nano-ESI-MS/MS permitiu o direto acoplamento da fibra SPME ao espectrômetro de massas via dessorção/ionização nanoeletrospray que resultou em rápida determinação quantitativa dos endocanabinóides em amostras biológicas. / This thesis is divided into three chapters. Chapter I describes the development of a column switching UHPLCMS/MS method to determine psychotropic drugs in schizophrenic patients plasma samples simultaneously. Polytherapy is a common practice in schizophrenia treatment. Therefore, therapeutic drug monitoring has been applied to adjust doses and to customize pharmacological therapy. The column switching UHPLCMS/MS method developed here is linear at concentrations ranging from 0.025 to 1.25 ng mL-1 with R2 above 0.9950 and presents lack of fit test (p > 0.05), precision with coefficients of variation lower than 12%, and accuracy with relative standard error lower than 14%. This method was successfully applied to determine drugs in schizophrenic patients plasma samples for therapeutic drug monitoring. In chapter II, the chromatographic performance of C18 superficially porous columns and of C18 fully porous columns with different particle sizes were evaluated for analysis of psychotropic drugs by LC-MS/MS and LC-DAD. Within the LC-MS/MS system, the following chromatographic parameters were assessed: reduced plate height vs reduced linear velocity, impedance vs reduced linear velocity, chromatographic run time vs flow rate, backpressure vs flow rate, resolution, peak capacity, asymmetry, and retention factor. Within the LC-DAD system, hydrophobicity, silanol activity, and metal impurities were also examined. Columns with charged surface displayed improved chromatographic efficiency for drugs in the ionized form. Columns with particles smaller than 2 µm (Cortecs 1.6 µm, Acquity 1.7 µm, and Kinetex 1.7 µm) presented higher chromatographic efficiency for the drugs, which were in their partially ionized form. The generated mathematical models were able to predict the backpressure and the chromatographic run time at different flow rates for all the columns. Considering efficiency, impedance, resolution, peak capacity, retention factor, and hydrophobicity, columns Cortecs 1.6 µm and Acquity 1.7 µm provided the best performance during analysis of drugs in plasma samples. Chapter III describes the development and validation of the SPME-UHPLC-MS/MS and the Bio-SPME-Nano-ESI-MS/MS methods for determination of endocannabinoids (AEA and 2-AG) in biological samples. To optimize the SPME process, SPME coatings (C18, C30, and HLB) and solvents for desorption (methanol, acetonitrile, and isopropanol) were evaluated. Matrix modifier additives, such as guanidine hydrochloride, trifluoroacetic acid, and acetonitrile, were assessed by experimental design. The SPME-UHPC-MS/MS and the Bio-SPME-Nano-ESI-MS/MS methods with HLB biocompatible coating provided LOQ values of 1 ng mL-1 and 50 ng mL-1, respectively, for both endocannabinoids. The Bio-SPME-Nano-ESI-MS/MS method allowed direct coupling of SPME fibers to the mass spectrometer by desorption/ionization nanoelectrospray, which resulted in rapid quantitative determinations of endocannabinoids in biological samples.

Das übergeordnete Ziel dieser Promotion war die Untersuchung und Kompensation des Matrixeffekts für die Analytik von Arzneimitteln in komplexen Probenmatrices mit LC-ESI-MS/MS-Technik. Zunächst konnte eine einfache analytische Methode für eine breite analytische Anwendbarkeit entwickelt werden. Es zeigte sich jedoch, dass die Matrixeffektkompensation zu einem Mehraufwand bei der Probenvorbereitung führt. Deshalb wurde anschließend der Mechanismus des Matrixeffektes auf die LC-ESI-MS/MS-Technik genauer untersucht. Die gewonnenen Erkenntnisse wurden anschließend eingesetzt, um eine einfache alternative Quantifizierungsmethode mittels der PCI eines internen Standards zu entwickeln. Im ersten Teilprojekt wurde eine LC-ESI-MS/MS-Methode für die Analytik von häufig verschriebenen Antibiotika in Abwasserproben der Stadt Dresden entwickelt. Da weder Vergleichsmatrix für Abwasser zur Verfügung stand, noch für alle Zielanalyte isotopenmarkierte Standards erhältlich sind, wurde der stark variierende Matrixeffekt der Abwasserproben mittels der Standardaddition kompensiert. Die Ergebnisse der Methodenentwicklung zeigen, dass eine genaue und flexible Methode entwickelt werden konnte, die Matrixkompensation jedoch zu einem erhöhten Zeit- und Materialaufwand führt. Es wurde deutlich, dass neben bisher genutzten Kompensationsmethoden für den Matrixeffekt, wie Standardaddition und interner isotopenmarkierter Standards, neue alternative Strategien getestet werden müssen. In dem zweiten Teilprojekt wurde daher der Matrixeffektmechanismus von Urin-, Plasma- und verschiedenen Abwasserproben bei der Messung von verschiedenen Arzneimitteln mittels LC-ESI-MS/MS analysiert. Die Ergebnisse der Untersuchungen mittels „post-column infusion“ konnten bisherige Erkenntnisse zu Matrixeffektmechanismen bestätigen und das Verständnis vertiefen. Matrixeffekte sind von der jeweiligen Zusammensetzung der Probenmatrix abhängig, aber auch substanzspezifisch. Dabei kommt es zwischen Analyt und Begleitsubstanzen zu einer Konkurrenz um freie Ladungsträger oder zu einer veränderten Anordnung/Verteilung innerhalb der ESI-Spray-Tröpfchen. Gleichzeitig zeigten die Ergebnisse, dass es auch andere Mechanismen, wie z. B. Ladungstransfers zwischen Analyt und Begleitsubstanzen, geben muss. Schließlich wurden die Ergebnisse des zweiten Teilprojekts in einer innovativen Methodenentwicklung zur Matrixkompensation und zur Quantifizierung von 16 Arzneimitteln in Urinproben verwendet. Der Matrixeffekt der Substanzen mit vergleichbarer Signalsuppression konnte über einen einzelnen nachsäuleninfundierten internen Standard kompensiert werden. Die Ergebnisse zeigen einen deutlichen Vorteil der entwickelten Methode gegenüber Matrix-Kalibrierung in Präzision und Richtigkeit oder dem Einsatz von isotopenmarkierten internen Standards in Aufwand der Methodenentwicklung und Verbrauch von Standardsubstanzen. Die Ergebnisse der vorliegenden Arbeit zeigen die Bedeutung, Komplexität und den Einfluss der Matrixeffekte in der Anwendung der LC-ESI-MS/MS-Technik. Einerseits sind geeignete Methoden für die Minimierung von Matrixeffekten wie Probenvorbereitung und Chromatographie nötig, andererseits müssen Ionisierungsmechanismen, insbesondere die Wechselwirkungen von Zielanalyten und Begleitsubstanzen, zukünftig Gegenstand weiterer Untersuchungen sein. Die Ergebnisse dieser Arbeit liefern wichtige Beiträge zur Verbesserung der Analytik von komplexen Proben mittels der LC-ESI-MS/MS-Technik. / The overall goal of this Ph.D. thesis was to investigate and compensate the matrix effect of the analysis of drugs in complex sample matrices with LC-ESI-MS/MS technique. First, a simple analytical method for a broad analytical applicability was developed for wastewater analysis. However, the matrix effect compensation embraced the main part effort in sample preparation. Therefore, the mechanism of the matrix effect on the LC-ESI-MS/MS technique was examined in more detail. The findings were used to develop an alternative quantification method using post-column infusion of an internal standard substance. In the first project, a LC-ESI-MS/MS method was developed to analyze commonly prescribed antibiotics in wastewater samples of Dresden. Since neither comparison matrix for wastewater nor all isotopically-labeled analogs for the target analytes were available, the strongly varying matrix effect of the wastewater samples was compensated by standard addition. The results show that the developed method is precise and flexible, but the matrix effect compensation leads to an increased expenditure of time and materials. Besides previously used matrix effect compensation methods, such as standard addition and internal isotopically-labeled standard, new alternative strategies need to be tested. Therefore, the matrix effect mechanism of various drugs and sample matrix combinations was examined in the second project using post-column infusion. The results confirmed previous findings on matrix effect mechanisms and deepened our understanding that matrix effects not only depend on the composition of the sample matrix but are also substance-specific. This results to a competition of free charge carriers between analyte and accompanying substances or to an alternated distribution within the ESI spray droplets. Furthermore, the results indicate that there are other mechanisms, such as charge transfer between analyte and concomitant substances. The results of the second project were used to invent a method for matrix effect compensation and quantification of 16 drugs in urine samples. The matrix effects of the substances with comparable signal suppression were compensated by a single post-column infused internal standard. The developed method has a significant advantage over the matrix calibration regarding precision and accuracy as well as the use of isotopically-labeled internal standards in effort of method development and consumption of standard substances. Finally, the results of this work show the importance, complexity and influence of the matrix effects in the application of the LC-ESI-MS/MS-technique. Suitable methods for minimizing matrix effects such as sample preparation and chromatography are needed and ionization mechanisms, in particular the interactions of target analytes with accompanying substances, should be investigated in future studies. The work of this Ph.D. project contributes to the improvement of the analysis of complex samples using the LC-ESI-MS/MS-technique.

The fatty acid amides, a structurally diverse endogenous congener of molecules active in cell signaling, may prove to have diverse activity due to their interface with a number of receptor systems, including, but not limited to cannabinoid receptor 2 (CB2) and PPARγ. Select extracts of Echinacea spp. contain the fatty acid amides known as alkylamides. These extracts were a previously popular remedy relied on by U.S. physicians, one of the top sellers in the natural products industry and are currently a frequently physician prescribed remedy in Germany. In the series of experiments contained within, Galenic ethanolic extracts of Echinacea spp. root were used for the quantification, identification, degradation and bioactivity studies. On extraction, depending on the ratio of plant to solvent and fresh or dry, the data indicate that there is variability in the alkylamide classes extracted. For example the acetylene alkylamides appear to extract under different concentrations, as well as degrade faster than the olefinic alkylamides. In addition, the alkylamides are found to degrade significantly in both cut/sift and powdered forms of echinacea root. Human liver microsome oxidation of the major alkylamide dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide generate hydroxylated, caboxylated and epoxidized metabolites. The carboxylated metabolite has, thus far, shown different immune activity than the native tetraene isobutylamide. Bioactivity studies, based on cytokine modulation of the alkylamides have been assumed to be due to a classic CB2 response. However, the results of experiments contained herein suggest that IL-2 inhibition by the alkylamide undeca-2E-ene-8,10-diynoic acid isobutylamide, which does not bind to CB2, is due to PPARγ activation. These data, combined with data generated by other groups, suggest that the alkylamides of Echinacea spp. are polyvalent in effect, in that they modulate multiple biochemical pathways.

Platinum-based drugs are an important group of alkylating-like agents which are used in cancer chemotherapy treatment. Cisplatin and oxaliplatin in particular are still commonly used today and are the focus of this thesis. As with most chemotherapy drugs, the efficacy of these drugs are limited by toxicity as well as tumour resistance, and therefore by increasing our understanding of these areas it is hoped to one day achieve personalised chemotherapy. The use of ICP-MS in the study of bio-sciences is still relatively new, however it has the ability to provide robust, fast and accurate methods for the quantification of platinum in biological samples. The research presented here utilised mass spectrometry in the study of the formation of Pt-DNA adducts in the clinical samples, the binding of oxaliplatin to short peptides and the effect of selenium supplementation on oxaliplatin in colorectal cancer cell lines. A comparison in the number of Pt-DNA adducts in saliva and leukocyte samples obtained from patients undergoing Pt-based chemotherapy demonstrated a lack of correlation between the two sample types. Samples were taken pre- and post-treatment and analysed via SF-ICP-MS and significant inter-patient variability was observed as expected. In both leukocyte and saliva samples, not only was Pt from previous chemotherapy cycles observed, but Pt was detected in the DNA in both sample types 1 hour after treatment. However a lack of correlation between platinum levels seen in the blood and saliva, combined with unexpected difficulties obtaining patient adherence to the saliva sampling protocol, indicated that saliva does not at present offer a reliable alternative to leukocytes for this assay. The binding of oxaliplatin to short nitrogen and sulfur rich peptides was investigated. Platinum binding to the peptides was observed and no significant differences in the level of binding were observed between the range of N and S rich peptides studied in this investigation. Partly due to the inability to reproduce biological conditions in this study, oxaliplatin was observed as a whole molecule, and furthermore dimers and multimers were also observed. The effect of selenium supplementation on the total cellular uptake of platinum was investigated in cultured cells via ICP-MS and LA-ICP-MS. It was observed that selenium decreased the amount of Pt taken up by the cancer cells. This was seen in analysis of populations of cells as well as by single cell analysis. Furthermore, while problems were encountered measuring selenium in subcellular experiments, the effect of selenium on the subcellular distribution of platinum as well as the number of Pt-DNA adducts could be determined.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

Mass spectrometry is a versatile analytical tool for chemical and biomolecule identification, quantitation, and structural analysis. Tandem mass spectrometry further expands the applications of mass spectrometry, making it more than a mere detector. With tandem mass spectrometry, the mass spectrometer is capable of probing reaction mechanisms, monitoring reaction processes, and performing fast analysis on complex samples. In tandem mass spectrometry, after activation the precursor ions fragment into small fragment ions through one or more pathways, which are affected by the ion’s inherit property, the ion type, and the activation method. To obtain complementary information, one can alter the fragmentation pathway by changing the ion via ion charge manipulation and covalent modification to the ion. Gas-phase ion/ion reactions provide an easy approach to changing ion type and facile modification to the analyte ions. It has been extensively used for spectrum simplification and analyte structural studies. In this dissertation, ion/ion reaction facilitated mass spectrometry methods are studied, and explorations into the method development involving front-end mass spectrometer are discussed.<br>The first work demonstrates a special rearrangement reaction for gas-phase Schiff-base-modified peptides. Gas-phase Schiff-base modification of peptides has been applied to facilitate the primary structural characterization via tandem mass spectrometry. A major or minor fragment pathway related to the novel rearrangement reaction was observed upon in-trap collisional activation of the gas-phase Schiff-base-modified peptides. The rearrangement reaction involves the imine of the Schiff base and a nucleophile present in the polypeptide. The occurrence of the rearrangement reaction is affected by several factors, such as ion polarity, identity of the nucleophile in the peptide (e.g., side chains of lysine, histidine, and arginine), and the position of the nucleophile relative to the imine. The rearrangement reaction does not affect the amount of structural information that can be obtained by collisional activation of the Schiff-base-modified peptide, but when the rearrangement reaction is dominant, it can siphon away signal from the structurally diagnostic processes.<br>Efforts have also been put into the method development of peptide and protein aggregation detection via electrospray ionization mass spectrometry (ESI-MS). People have studied peptide and protein aggregation processes to understand the mechanism of amyloid-related diseases and to control the quality of the peptide and protein pharmaceuticals. ESI-MS is suitable for solution aggregation studies because of its compatibility with solution samples and the straightforward result of the analyte’s oligomeric state on the mass spectrum. However, peak overlap issue and nonspecific aggregation in the ESI process can obscure the result. Here, the application of proton transfer ion/ion reaction to the analyte has been found useful to reduce or eliminate the peak overlap issue. A statistical model based on Poisson statistics has been proposed to deal with the ESI-induced nonspecific aggregation in the droplet and to differentiate the solution-phase aggregation from the droplet-induced aggregation. Factors that affect the accuracy of the statistical model have been discussed with MATLAB simulations.<br>In the era of biological system studies, sample complexity is a challenge every analytical chemist has to face. The analysis of complex sample can be facilitated by the combination of separation techniques outside the mass spectrometer (such as differential mobility spectrometry (DMS)) and ion structure probing techniques inside the mass spectrometer (such as tandem mass spectrometry and gas-phase ion/ion reactions). Here the coupling method between DMS and ion/ion reaction is developed and tested with model peptide systems to demonstrate its possible application in complex sample characterization such as isomer identification.<br>